Halper Sadeh expands sale-term probes to Beazer, Arcosa, Synaptics and Crinetics

Halper Sadeh LLC broadened its Aug. 6-8 series of shareholder-rights reviews with a new release covering Beazer Homes USA, Inc.'s sale to Dream Finders Homes, Inc. for $33.50 in cash per share, Arcosa, Inc.'s sale to CRH for $150.00 per share, Synaptics Incorporated's sale to onsemi for 1.350 shares of onsemi common stock for each Synaptics share, and Crinetics Pharmaceuticals, Inc.'s sale to Vertex Pharmaceuticals Incorporated for $85.00 per share in cash. The latest notice follows earlier Aug. 7 and Aug. 6 releases involving Bowhead Specialty Holdings, Supernus Pharmaceuticals, Atkore, Distribution Solutions Group, Lantheus Holdings, DoubleVerify Holdings, Integer Holdings, MarketAxess Holdings, Sanara MedTech, Forte Biosciences, Luxfer Holdings, Dominion Energy and NextEra Energy, including Lantheus' cash deal with Curium US Holdings LLC plus non-transferable Contingent Value Rights worth up to $12.00 per share if specified commercial milestones are met through 2030. Across the combined releases, the firm has identified 17 distinct announced transactions for potential federal securities law violations or breaches of fiduciary duties, saying insiders may receive benefits unavailable to ordinary shareholders and that deal terms may restrict superior competing offers. The firm said it may seek increased consideration, added disclosures or other relief on a contingent fee basis.